Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapyZehua Ma, Wei Xue, Weiwei Zhang et al.|Theranostics|2022Cited by 119
Squalene Epoxidase Metabolic Dependency Is a Targetable Vulnerability in Castration-Resistant Prostate CancerXun Shangguan, Jun Qi, Zehua Ma et al.|Cancer Research|2022Cited by 51
Identification of cancer-associated fibroblasts subtypes in prostate cancerJiahua Pan, Wei Xue, Бо Лю et al.|Frontiers in Immunology|2023Cited by 43
Tumour tissue‐derived small extracellular vesicles reflect molecular subtypes of bladder cancerLiang Dong, Kenneth J. Pienta, Mingxiao Feng et al.|Journal of Extracellular Vesicles|2024Cited by 16
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancerLiang Dong, Kenneth J. Pienta, Cong Hu et al.|Medical Oncology|2024Cited by 12